Evidence map›Paper›PMID 33668605›Full record

ArticleInternational journal of molecular sciences2021

Arsenoplatin-Ferritin Nanocage: Structure and Cytotoxicity.

Giarita Ferraro, Alessandro Pratesi, Damiano Cirri, Paola Imbimbo, Daria Maria Monti, Luigi Messori, Antonello Merlino

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Giarita FerraroDepartment of Chemistry "Ugo Schiff", University of Florence, Via Della Lastruccia, 3-13, Sesto Fiorentino, 50019 Florence, Italy.ORCID 0000-0001-9385-2429
Alessandro PratesiDepartment of Chemistry and Industrial Chemistry, University of Pisa, Via Giuseppe Moruzzi 13, 56124 Pisa, Italy.ORCID 0000-0002-9553-9943
Damiano CirriDepartment of Chemistry and Industrial Chemistry, University of Pisa, Via Giuseppe Moruzzi 13, 56124 Pisa, Italy.ORCID 0000-0001-9175-9562
Paola ImbimboDepartment of Chemical Sciences, University of Naples Federico II, Via Cinthia 21, 80126 Naples, Italy.ORCID 0000-0002-5491-2297
Daria Maria MontiDepartment of Chemical Sciences, University of Naples Federico II, Via Cinthia 21, 80126 Naples, Italy.ORCID 0000-0002-1136-0576
Luigi MessoriDepartment of Chemistry "Ugo Schiff", University of Florence, Via Della Lastruccia, 3-13, Sesto Fiorentino, 50019 Florence, Italy.ORCID 0000-0002-9490-8014
Antonello MerlinoDepartment of Chemical Sciences, University of Naples Federico II, Via Cinthia 21, 80126 Naples, Italy.ORCID 0000-0002-1045-7720
University of Naples Federico II · ITUniversity of Florence · ITUniversity of Pisa · IT

Funding

Associazione Italiana per la Ricerca sul Cancro 22587
6 · The paper itself

Abstract

Arsenoplatin-1 (AP-1), the prototype of a novel class of metallodrugs containing a PtAs(OH)

Indexed as

Antineoplastic AgentsCytotoxinsFerritinsPlatinum CompoundsAnimalsArsenic TrioxideBALB 3T3 CellsCisplatinHumansMiceMolecular StructureNeoplasmsStructure-Activity RelationshipAntineoplastic AgentsArsenic Trioxidearsenoplatin-1CisplatinCytotoxinsFerritinsPlatinum Compoundsanti-cancer activityAs compoundsferritin encapsulationmetal complexesmetallodrugsprotein metalationPt compounds

Identifiers

PMID33668605
PMCPMC7918638
OpenAlexW3131899446

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.